Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Clinical Efficacy of Non-Statin Treatment Options in ASCVD
Focusing on PCSK9 inhibitors, inclisiran, and bempedoic acid, the panel compares treatment efficacy and outlines patient factors that influence treatment decisions.
EP: 1.How Often Do Patients with ASCVD Achieve Target LDL-C?
EP: 2.Gaps Between Guidelines and Clinical Practice Patterns in ASCVD
EP: 3.Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines
EP: 4.Key Barriers in Implementing Guideline-Directed Cholesterol Treatment
EP: 5.Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD
Now Viewing
EP: 6.Clinical Efficacy of Non-Statin Treatment Options in ASCVD
EP: 7.Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps
EP: 8.Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD
EP: 9.The Role of Pharmacists in Treating Very High-Risk ASCVD
EP: 10.Valuable Metrics and Improving Adherence in Patients With ASCVD
EP: 11.Successful Collaborative Care Strategies for Pharmacists
Recent Videos
Related Content
